胆汁酸性腹泻与腹泻型肠易激综合征的生化、微生物及黏膜mRNA表达比较
该研究比较了无胆汁酸吸收不良的腹泻型肠易激综合征(IBS-D)患者与胆汁酸性腹泻(BAD,血清7C4>52 ng/mL)患者的生化参数、结肠传输、直肠感觉、胆汁酸相关基因、回肠和结肠黏膜mRNA及粪便菌群失调。结果显示,与161例无ABAM的IBS-D患者相比,44例BAD患者结肠传输更快、微生物α多样性更低、菌群构成不同、厚壁菌门与拟杆菌门比值更高,并伴有胆汁酸硫代连接酶和硫酸酯酶表达降低;BAD患者回肠SLC44A5下调,升结肠CLDN2等基因上调,两组直肠感觉相似。
要点
- BAD患者较无ABAM的IBS-D患者结肠传输更快、微生物α多样性更低、厚壁菌门与拟杆菌门比值更高。
- BAD患者回肠SLC44A5(胆汁酸转运体)表达下调,升结肠屏障削弱基因CLDN2等上调。
- BAD与IBS-D临床症状相似,但存在生物学差异,可能有助于靶向诊断和治疗。
核心结论
- BAD虽与IBS-D共享临床症状,但存在生物学差异和机制,可能有助于针对屏障功能障碍、炎症和微生物变化的诊断与治疗。
研究设计与样本
- 在符合罗马III标准IBS-D的患者中,比较生化特征、结肠传输、直肠感觉、5个胆汁酸相关基因的深度基因型、回肠和结肠黏膜mRNA差异表达分析及粪便菌群失调(含微生物组功能分析)。
- 将BAD(血清7C4>52 ng/mL)患者的结果与无ABAM的IBS-D患者进行比较。
主要发现
- 与161例无ABAM的IBS-D患者相比,44例BAD患者结肠传输显著更快、微生物α多样性更低、菌群构成不同(β多样性)且厚壁菌门与拟杆菌门比值更高,并有证据显示胆汁酸硫代连接酶(参与初级向次级胆汁酸转化)和硫酸酯酶表达降低。
- BAD患者(与无ABAM的IBS-D相比)末端回肠活检显示SLC44A5(胆汁酸转运体)下调,升结肠活检显示屏障削弱基因(CLDN2)、丝氨酸蛋白酶抑制剂、免疫激活、细胞分化和细胞转运体(FABP6;胆汁酸结合)上调。
- 降结肠活检中未记录到基因差异表达。
- 两组直肠感觉相似。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: There are altered mucosal functions in irritable bowel syndrome with diarrhoea (IBS-D); ~30% of patients with IBS-D have abnormal bile acid (BA) metabolism (ABAM) and diarrhoea (summarised as BAD). AIM: To compare biochemical parameters, gastrointestinal and colonic transit, rectal sensation and pathobiological mechanisms in IBS-D without ABAM and in BAD (serum 7C4>52 ng/mL). DESIGN: In patients with Rome III criteria of IBS-D, we compared biochemical features, colonic transit, rectal sensation, deep genotype of five BA-related genes, ileal and colonic mucosal mRNA (differential expression (DE) analysis) and stool dysbiosis (including functional analysis of microbiome). Results in BAD were compared with IBS-D without ABAM. RESULTS: Compared with 161 patients with IBS-D without ABAM, 44 patients with BAD had significantly faster colonic transit, lower microbial alpha diversity, different compositional profile (beta diversity) and higher Firmicutes to Bacteroidetes ratio with evidence of decreased expression of bile acid thiol ligase (involved in transformation of primary to secondary BAs) and decreased sulfatases. In BAD (compared with IBS-D without ABAM), terminal ileal biopsies showed downregulation of SLC44A5 (a BA transporter), and ascending colon biopsies showed upregulation in barrier-weakening genes (CLDN2), serine protease inhibitors, immune activation, cellular differentiation and a cellular transporter (FABP6; BA binding). No DE of genes was documented in descending colon biopsies. The two groups had similar rectal sensation. CONCLUSION: Though sharing clinical symptoms with IBS-D, BAD is associated with biological differences and mechanisms that have potential to enhance diagnosis and treatment targeting barrier dysfunction, inflammatory and microbial changes.
引用
- Camilleri M, Carlson P, BouSaba J, et al. Comparison of biochemical, microbial and mucosal mRNA expression in bile acid diarrhoea and irritable bowel syndrome with diarrhoea. Gut. 2022. PMID: 35580964. doi:10.1136/gutjnl-2022-327471
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。